Entrada Therapeutics, Inc.(TRDA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TRDA Entrada Therapeutics, Inc.

休市中 05-17 16:00:00 EDT

14.99

+0.04

+0.27%

盘后14.99

+0.000.00%

16:06 EDT

最高15.34	最低14.78	成交量10.49万
今开15.34	昨收14.95	日振幅3.75%
总市值5.06亿	流通市值2.28亿	总股本3,376万
成交额158.29万	换手率0.69%	流通股本1,523万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TRDA","market":"US","secType":"STK","nameCN":"Entrada Therapeutics, Inc.","latestPrice":14.99,"timestamp":1715976000000,"preClose":14.95,"halted":0,"volume":104887,"hourTrading":{"tag":"盘后","latestPrice":14.99,"preClose":14.99,"latestTime":"16:06 EDT","volume":9638,"amount":144473.62,"timestamp":1715976398538},"delay":0,"floatShares":15226900,"shares":33758976,"eps":0.704599,"marketStatus":"休市中","marketStatusCode":7,"change":0.04,"latestTime":"05-17 16:00:00 EDT","open":15.34,"high":15.34,"low":14.78,"amount":1582910.341686,"amplitude":0.037458,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.704599,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1635480000000,"adjPreClose":14.95,"preHourTrading":{"tag":"盘前","latestPrice":14.95,"preClose":14.95,"latestTime":"08:45 EDT","volume":25,"amount":380.35,"timestamp":1715949932279},"postHourTrading":{"tag":"盘后","latestPrice":14.99,"preClose":14.99,"latestTime":"16:06 EDT","volume":9638,"amount":144473.62,"timestamp":1715976398538},"volumeRatio":1.3533142912011762},"requestUrl":"/m/hq/s/TRDA","defaultTab":"news","newsList":[{"id":"2435178105","title":"Entrada Therapeutics, Inc.盘中异动 快速上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435178105","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435178105?lang=zh_cn&edition=full","pubTime":"2024-05-14 22:46","pubTimestamp":1715698000,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日22时46分，Entrada Therapeutics, Inc.股票出现波动，股价急速上涨5.09%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc临床阶段生物制药公司，旨在通过建立一类新的药物来改变患者的生活，这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142246417927a0fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142246417927a0fc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433515747","title":"Entrada Therapeutics Inc   预计每股收益12美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433515747","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433515747?lang=zh_cn&edition=full","pubTime":"2024-05-08 19:42","pubTimestamp":1715168557,"startTime":"0","endTime":"0","summary":"   * Entrada Therapeutics Inc    将于8月6日公布截至2024年6月30日的业绩(估计)，预计该公司的季度收入将出现增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于波士顿马萨诸塞州的公司的营收预计将从去年同期的1817万美元增长74.4%，达到3168.1万美元。* LSEG 分析师对 Entrada Therapeutics Inc 的平均预期为每股收益 12 美分。* 华尔街对 Entrada Therapeutics Inc 的 12 个月目标价中位数为 21.00 美元，高于其上次收盘价 13.88 美元。5月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429611896","title":"Entrada Therapeutics, Inc.盘中异动 早盘股价大涨5.00%报13.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429611896","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429611896?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:57","pubTimestamp":1713880626,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时57分，Entrada Therapeutics, Inc.股票出现异动，股价快速上涨5.00%。截至发稿，该股报13.76美元/股，成交量4782股，换手率0.01%，振幅4.01%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc临床阶段生物制药公司，旨在通过建立一类新的药物来改变患者的生活，这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232157077922b122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232157077922b122&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426675682","title":"Entrada Therapeutics, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426675682","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426675682?lang=zh_cn&edition=full","pubTime":"2024-04-12 00:04","pubTimestamp":1712851491,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日00时04分，Entrada Therapeutics, Inc.股票出现波动，股价急速上涨5.19%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为679.36%、524.03%、498.73%，振幅较大的相关个股有Rallybio Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为50.92%、46.31%、40.90%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc的使命是通过开发细胞内生物制剂来改变破坏性疾病的治疗方法并改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412000451791ff4e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412000451791ff4e7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421777014","title":"Entrada Therapeutics, Inc.盘中异动 下午盘急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421777014","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421777014?lang=zh_cn&edition=full","pubTime":"2024-03-21 03:19","pubTimestamp":1710962352,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日03时19分，Entrada Therapeutics, Inc.股票出现波动，股价大幅上涨5.04%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc的使命是通过开发细胞内生物制剂来改变破坏性疾病的治疗方法并改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210319127a4dff8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210319127a4dff8e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417414058","title":"Entrada Therapeutics, Inc.盘中异动 股价大涨7.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417414058","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417414058?lang=zh_cn&edition=full","pubTime":"2024-03-05 22:31","pubTimestamp":1709649072,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日22时31分，Entrada Therapeutics, Inc.股票出现波动，股价大幅拉升7.59%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Apogee Therapeutics, Inc.、Regenxbio Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、CASI制药较为活跃，换手率分别为196.86%、87.59%、43.75%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Ocean Biomedical, Inc.、Tevogen Bio Holdings Inc.，振幅分别为15.24%、11.03%、9.21%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc的使命是通过开发细胞内生物制剂来改变破坏性疾病的治疗方法并改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030522311287e7616d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030522311287e7616d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416712897","title":"Entrada Therapeutics, Inc.盘中异动 早盘急速下挫5.54%报12.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416712897","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416712897?lang=zh_cn&edition=full","pubTime":"2024-03-04 23:22","pubTimestamp":1709565745,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日23时22分，Entrada Therapeutics, Inc.股票出现异动，股价急速下跌5.54%。截至发稿，该股报12.97美元/股，成交量3.2543万股，换手率0.10%，振幅5.54%。Entrada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Entrada Therapeutics, Inc.公司简介：Entrada Therapeutics Inc的使命是通过开发细胞内生物制剂来改变破坏性疾病的治疗方法并改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423222587e75b30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423222587e75b30&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416114822","title":"Entrada Therapeutics Inc   预计每股亏损17美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2416114822","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2416114822?lang=zh_cn&edition=full","pubTime":"2024-03-04 20:03","pubTimestamp":1709553787,"startTime":"0","endTime":"0","summary":"   * Entrada Therapeutics Inc    预计将在3月6日公布截至2023年12月31日的业绩(估计)，季度收入将有所增长。* LSEG 分析师对 Entrada Therapeutics Inc 的平均预期是每股亏损 17 美分。* 华尔街对 Entrada Therapeutics Inc 的 12 个月目标价中位数为 21.00 美元，高于其上次收盘价 13.73 美元。3月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406124153","title":"Entrada Therapeutics Inc盘中异动 股价大跌7.30%报14.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406124153","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406124153?lang=zh_cn&edition=full","pubTime":"2024-01-26 01:14","pubTimestamp":1706202880,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日01时14分，Entrada Therapeutics Inc股票出现异动，股价快速下挫7.30%。截至发稿，该股报14.35美元/股，成交量9085股，换手率0.03%，振幅4.97%。Entrada Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.09%。Entrada Therapeutics Inc公司简介：Entrada Therapeutics Inc的使命是通过开发细胞内生物制剂来改变破坏性疾病的治疗方法并改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401260114407a3e68f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401260114407a3e68f9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2405175890","title":"Entrada Therapeutics Inc盘中异动 早盘股价大涨5.33%报16.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2405175890","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2405175890?lang=zh_cn&edition=full","pubTime":"2024-01-23 23:26","pubTimestamp":1706023583,"startTime":"0","endTime":"0","summary":"北京时间2024年01月23日23时26分，Entrada Therapeutics Inc股票出现波动，股价快速上涨5.33%。截至发稿，该股报16.50美元/股，成交量3569股，换手率0.01%，振幅2.78%。Entrada Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.09%。Entrada Therapeutics Inc公司简介：Entrada Therapeutics Inc的使命是通过开发细胞内生物制剂来改变破坏性疾病的治疗方法并改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240123232623790b72ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240123232623790b72ac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404574075","title":"Entrada Therapeutics Inc盘中异动 大幅下跌6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2404574075","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404574075?lang=zh_cn&edition=full","pubTime":"2024-01-19 04:01","pubTimestamp":1705608106,"startTime":"0","endTime":"0","summary":"北京时间2024年01月19日04时01分，Entrada Therapeutics Inc股票出现波动，股价急速下挫6.19%。Entrada Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Jasper Therapeutics Inc C/Wts 24/09/2026 、Celularity Inc涨幅较大，Transcode Therapeutics Inc、Kintara Therapeutics Inc、Zyversa Therapeutics Inc较为活跃，换手率分别为444.38%、202.42%、67.64%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Transcode Therapeutics Inc、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为387.48%、71.71%、52.91%。Entrada Therapeutics Inc公司简介：Entrada Therapeutics Inc的使命是通过开发细胞内生物制剂来改变破坏性疾病的治疗方法并改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240119040146790a1cd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240119040146790a1cd3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404816334","title":"Entrada Therapeutics Inc盘中异动 股价大跌5.50%报15.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2404816334","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2404816334?lang=zh_cn&edition=full","pubTime":"2024-01-17 02:09","pubTimestamp":1705428579,"startTime":"0","endTime":"0","summary":"北京时间2024年01月17日02时09分，Entrada Therapeutics Inc股票出现波动，股价大幅下跌5.50%。截至发稿，该股报15.47美元/股，成交量9176股，换手率0.03%，振幅2.93%。Entrada Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.37%。Entrada Therapeutics Inc公司简介：Entrada Therapeutics Inc的使命是通过开发细胞内生物制剂来改变破坏性疾病的治疗方法并改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011702093987e65a02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011702093987e65a02&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402965052","title":"Entrada Therapeutics Inc盘中异动 早盘股价大涨5.29%报16.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402965052","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402965052?lang=zh_cn&edition=full","pubTime":"2024-01-08 23:56","pubTimestamp":1704729404,"startTime":"0","endTime":"0","summary":"北京时间2024年01月08日23时56分，Entrada Therapeutics Inc股票出现异动，股价快速拉升5.29%。截至发稿，该股报16.06美元/股，成交量1.0642万股，换手率0.03%，振幅5.25%。Entrada Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.06%。Entrada Therapeutics Inc公司简介：Entrada Therapeutics Inc的使命是通过开发细胞内生物制剂来改变破坏性疾病的治疗方法并改善患者的生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010823564587e64184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010823564587e64184&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.entradatx.com","stockEarnings":[{"period":"1week","weight":0.0453},{"period":"1month","weight":0.2267},{"period":"3month","weight":0.0424},{"period":"6month","weight":-0.0758},{"period":"1year","weight":0.184},{"period":"ytd","weight":-0.0066}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Entrada Therapeutics, Inc.于2016年9月22日根据特拉华州法律注册成立。该公司旨在通过将内体逃逸载体(EEV)疗法确立为一种新型药物来改变患者的生活，并致力于成为世界上最重要的细胞内疗法公司。该公司的EEV疗法旨在处理长期以来被认为无法接近和无法成药的细胞内靶标。通过其专有的、高度通用的模块化EEV平台，他们正在构建强大的EEV治疗候选药物开发组合，旨在使治疗剂在各种器官和组织中有效细胞内递送，并提高治疗指数。该公司相信，他们早期项目的潜在成功可以转化为有效开发其他EEV治疗候选药物，并使他们能够在罕见疾病、免疫学和肿瘤学方面建立投资组合。","exchange":"NASDAQ","name":"Entrada Therapeutics, Inc.","nameEN":"Entrada Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Entrada Therapeutics, Inc.(TRDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Entrada Therapeutics, Inc.(TRDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Entrada Therapeutics, Inc.,TRDA,Entrada Therapeutics, Inc.股票,Entrada Therapeutics, Inc.股票老虎,Entrada Therapeutics, Inc.股票老虎国际,Entrada Therapeutics, Inc.行情,Entrada Therapeutics, Inc.股票行情,Entrada Therapeutics, Inc.股价,Entrada Therapeutics, Inc.股市,Entrada Therapeutics, Inc.股票价格,Entrada Therapeutics, Inc.股票交易,Entrada Therapeutics, Inc.股票购买,Entrada Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Entrada Therapeutics, Inc.(TRDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Entrada Therapeutics, Inc.(TRDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}